Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE.
Colgate-Palmolive stock has delivered a 32.3% return over the past three years, yet the current checks send mixed signals on value, with the Discounted Cash Flow (DCF) intrinsic value estimate suggesting upside while traditional earnings multiples look expensive.
A 32.3% three year return shows the stock has already rewarded investors, which can reduce the margin of safety if expectations are high.
Ongoing demand for everyday household products can support cash flow expectations, while any pressure on input costs or pricing power may weigh on the valuation investors are willing to pay.
Colgate-Palmolive scores 2 out of 6 on the broader valuation checks, which leans more toward expensive than clear bargain territory on the full scorecard.
For investors, the key question is whether Colgate-Palmolive's current share price already reflects the cash flows implied by the DCF estimate, or whether the richer market multiples and low score suggest limited upside from here.
Colgate-Palmolive delivered 10.8% returns over the last year. See how this stacks up to the rest of the Household Products industry.
The Discounted Cash Flow (DCF) method looks at the cash Colgate-Palmolive can generate for shareholders over time and discounts it back to today. For Colgate-Palmolive, the model uses latest twelve month free cash flow of about $3.85b and assumes that cash flows continue to grow rather than shrink.
On that basis, the 2 Stage Free Cash Flow to Equity model arrives at an estimated intrinsic value of about $130.82 per share. Compared with the current share price, this implies an intrinsic discount of 29.7%, which suggests the market price is below what these projected cash flows would support if they play out as modeled.
On this DCF view, Colgate-Palmolive stock currently screens as undervalued relative to its estimated intrinsic value.
Our Discounted Cash Flow (DCF) analysis suggests Colgate-Palmolive is undervalued by 29.7%. Track this in your watchlist or portfolio, or discover 52 more high quality undervalued stocks.
Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Colgate-Palmolive.
P/E suits Colgate-Palmolive because earnings remain a core reference point for a mature consumer staples business. The stock currently trades at a P/E of about 36.0x, which is well above the Household Products industry average of 17.6x and also higher than the peer group average of 24.3x. This already places Colgate-Palmolive on a clear premium footing compared with many sector peers.
The fair P/E ratio, which reflects what investors might typically pay given Colgate-Palmolive's profile, sits at about 24.3x. That is materially below the current 36.0x level, so the stock is pricing in a much richer earnings valuation than this tailored benchmark implies. For investors, that gap suggests expectations embedded in the share price are elevated relative to what the fair P/E framework would indicate.
On the P/E multiple, Colgate-Palmolive stock appears overvalued compared with both its fair ratio and wider industry benchmarks.
See what the numbers say about this price — find out in our valuation breakdown.
Simply Wall St Narratives pick up where the Colgate-Palmolive valuation puzzle leaves off and set out what would need to happen to growth, margins and earnings for the stock to trade materially higher or lower than today's price. Each narrative links its number to a specific view on how Colgate-Palmolive's growth, profitability and risks might evolve, which you can revisit and compare as fresh information is released on the Community page.
Colgate-Palmolive splits the community, with one scenario leaning on global growth and another focused on whether the current multiple already prices that in.
"Expansion and premiumization of core oral care lines like Colgate Total, coupled with the roll-out of complementary products across 75 markets, are set to capture increased value from emerging middle-class consumers and rising health/hygiene awareness globally, supporting top-line organic sales acceleration and improved pricing power…"
Read the full Bull Case to see why Colgate-Palmolive could be undervalued
"This creates a trap worth naming. If you normalise the margin but leave the future multiple at the GAAP-derived figure, you count the adjustment twice and overstate fair value by roughly 45%…"
Read the full Bear Case to see why Colgate-Palmolive could be overvalued
Do you think there's more to the story for Colgate-Palmolive? Head over to our Community to see what others are saying!
Colgate-Palmolive sits at the crossroads of two conflicting signals. The Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside from today's price, while the P/E based view flags the stock as overvalued compared with peers and its own fair ratio. The broader checks are weak, which softens the message from the DCF signal and suggests the premium multiple carries real expectations risk. The key question from here is whether Colgate-Palmolive can sustain the earnings power and cash generation needed to keep that premium multiple intact, rather than see it drift back toward the fair level.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include CL.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]